Nav: Home

Figuring out the fovea

February 21, 2019

When it comes to understanding how neurons connect to form circuits in the brain, scientists for decades have turned to the retina of the humble laboratory mouse as an ideal model organism. But as a model for vision and vision-related diseases, mice simply aren't equipped.

The problem, said Joshua Sanes, the Jeff C. Tarr Professor of Molecular and Cellular Biology and Director of the Center for Brain Science, is they lack a fovea - a small specialized area in the retina that makes sharp central vision possible. Among mammals, only primates have a fovea, making it all but impossible to study such questions in mice.

And though the fovea has been well-studied for decades - researchers have demonstrated both functional and structural specialization in foveal cells - the mechanisms that give rise to those differences have remained a mystery.

To begin unraveling that mystery, a team of researchers led by Sanes, applied high-throughput genetic sequencing methods to create the first cellular atlas of the primate retina, and found that while the fovea and peripheral retina share most of the same cell types, cells are found in different proportions in each region, and many show different gene expression patterns.

The study, Sanes said offers an important foundation for researchers to build on as they seek to understand how vision works in primates, including humans, and how vision can be disrupted by disease. The work is described in a paper published in Cell on February 21.

To create the cellular atlas, Sanes and colleagues began with 165,000 cells collected from the retinas of macaques - about half of which were foveal cells and half of which were peripheral cells - then used genetic tools to separate them into their various types.

In total, Sanes said, the team identified between 65 and 70 separate types in both the foveal and peripheral cells as well as the genes each type express, and the results produced both good and bad news.

The good news, Sanes said, was that they also came up with ideas about what makes the fovea special.

"About 90 percent of the cell types are shared, but what is more telling is that...they express a lot of different genes," Sanes said. "We believe that looking at those genes will help us explain a lot of the functional difference between a cell in the fovea and one in the periphery."

The bad news, he said, was that, when the team tried to find mouse equivalents of the main type that sends message from the fovea to the brain, named the "midget ganglion cell," named for their small size, they largely came up empty.

"Unfortunately, 'midgets' are the vast majority of foveal ganglion cells," Sanes said. "We'd hoped we would find the mouse equivalent of those we could study them using all the tools we've already developed, but we didn't. So that was a disappointment."

Armed with that cellular atlas, Sanes and colleagues turned to nearly 200 genes implicated in blinding diseases, and found that some, particularly those associated with macular degeneration and diabetic macular edema, are expressed in foveal cells - a tantalizing clue for why such diseases effect the fovea. The macula is a slightly larger region of the retina with the fovea at its center so "this pattern makes sense," says Sanes.

"For example, we found one macular degeneration susceptibility gene is expressed at substantially higher levels in foveal rods and cones than in peripheral rods and cones," Sanes said. "That may be related to the fact that it's a macular disease. Similarly for diabetic macular edema, we found two susceptibility genes expressed at higher levels in the blood vessels in the fovea than the periphery. These two diseases are among the leading causes of blindness in the U.S. and much of the world.

"We also took those genes back to the mouse cellular atlas, and in many cases they either weren't expressed or were expressed in different cells," Sanes continued. "That suggests that, for at least some of these diseases, looking at how a gene is acting in mice may not be very telling, because it may not be expressed in the same cells."

Going forward, Sanes said, the cellular atlas could serve as a valuable resource both for studies focused on specific diseases as well as basic science questions.

"On the disease side, just by having this knowledge we may be able to think about better treatments," Sanes said. "This could also be a foundation for looking at pathological material. We are collaborating with people who have banked eyes over the years for various purposes, which means we could begin to test hypotheses - so if we think perhaps people with glaucoma are missing a certain cell type or the expression of a gene is too low or too high, we can test that.

"On the basic research side, we can take a gene that we may have reason to think could play a role in the physiological differences in the cells and put it in a mouse cell and see if it changes the properties of that cell," he continued. "This will give us a big head start as we look to answer these kind of questions."
This research was supported with funding from the National Eye Institute, part of the National Institutes of Health, the Broad Institute and the BrightFocus Foundation.

Harvard University

Related Macular Degeneration Articles:

Dietary and lifestyle recommendations for patients at risk of macular degeneration
Age-related macular degeneration (AMD) is a major cause of severe visual impairment in older populations and is characterized by progressive destruction of the retinal pigment epithelial cells and photoreceptors due to low-grade inflammation, ischemia and oxidative stress.
Penn team characterizes the underlying cause of a form of macular degeneration
Using an animal model of Best disease in combination with biochemical and optical assays, a team of researchers at the University of Pennsylvania has pinpointed a number of abnormalities that give rise to the impairments seen in the blinding disease.
Communication from doctors could reduce anxiety for macular degeneration patients
Highly effective current treatments for vision loss need to be allied with careful counselling to ensure patients maintain good psychological health as well as good vision, new research recommends.
Assessing the impact of stress in age-related macular degeneration
Age-related macular degeneration (AMD), the leading cause of vision loss among older adults in the United States, is often associated with psychological stress.
Genetic mutations that lead to macular degeneration blindness mapped by new research
Two gene mutations that trigger a retinal disease that causes blindness in one in 5,000 males have been mapped, leading to the potential for new therapeutic treatments.
Clinical trial tests cord tissue to treat macular degeneration
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.
Macular degeneration insight identifies promising drugs to prevent vision loss
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
BrightFocus Foundation honors 5 researchers on macular degeneration and glaucoma
BrightFocus Foundation today recognized five scientists in the fields of macular degeneration and glaucoma research, awarding them grants named in honor of leaders in vision research and advocacy.
Age-related macular degeneration before and after the era of anti-VEGF drugs
In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye.
Discovery identifies new RX target for age-rleated macular degeneration & Alzheimer's
For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body's ability to remove waste products from the brain and retina is diminished in age-related macular degeneration, after first making the discovery in an Alzheimer's disease brain.

Related Macular Degeneration Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".